Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.19.3.a.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue $ 13,917 $ 11,332
Cost of revenue 7,153 7,023
Gross profit 6,764 4,309
Operating expenses:    
Sales and marketing 11,398 13,827
Research and development 4,596 5,847
General and administrative 7,409 11,665
Total operating expenses 23,403 31,339
Loss from operations (16,639) (27,030)
Other income, net:    
Interest expense (384) (600)
Finance cost associated with warrant issuance (1,096) 0
Gain on warrant liabilities 6,376 1,063
Loss on modification of warrants (257) 0
Other expense, net (132) (425)
Total other income, net 4,507 38
Net loss (12,132) (26,992)
Foreign currency translation adjustments 142 248
Comprehensive loss $ (11,990) $ (26,744)
Basic and diluted net loss per share applicable to common shareholders (in dollars per share) $ (0.17) $ (0.44)
Weighted average number of shares outstanding, basic and diluted (in shares) 71,911 61,229